Get the Stockscreener App
12.93
1.57%
0.20
Rapt Therapeutics Inc stock is traded at $12.93, with a volume of 91,956.
It is up +1.57% in the last 24 hours and up +28.02% over the past month.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
See More
Previous Close:
$12.73
Open:
$12.68
24h Volume:
91,956
Relative Volume:
0.91
Market Cap:
$213.83M
Revenue:
$3.25M
Net Income/Loss:
$-116.80M
P/E Ratio:
-4.2393
EPS:
-3.05
Net Cash Flow:
$-98.17M
1W Performance:
+13.62%
1M Performance:
+28.02%
6M Performance:
+43.03%
1Y Performance:
-16.26%
1-Day Range:
$12.55
$13.66
1-Week Range:
$11.14
$13.66
52-Week Range:
$5.6652
$26.56
Rapt Therapeutics Inc Stock (RAPT) Company Profile
Name
Rapt Therapeutics Inc
Sector
Industry
Phone
(650) 489-9000
Address
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Compare RAPT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RAPT
Rapt Therapeutics Inc
|
12.93 | 210.53M | 3.25M | -116.80M | -98.17M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Upgrade | JP Morgan | Underweight → Neutral |
| May-22-25 | Resumed | H.C. Wainwright | Buy |
| Dec-26-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Nov-13-24 | Downgrade | Stifel | Buy → Hold |
| Nov-11-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-11-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-14-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| May-10-24 | Downgrade | Barclays | Overweight → Equal Weight |
| May-10-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-22-24 | Downgrade | UBS | Buy → Neutral |
| Feb-21-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-21-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-21-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-20-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Feb-16-24 | Initiated | Evercore ISI | Outperform |
| Feb-15-24 | Initiated | Wolfe Research | Outperform |
| Sep-14-23 | Initiated | Berenberg | Buy |
| Aug-09-23 | Initiated | Stifel | Buy |
| Jun-15-23 | Initiated | Barclays | Overweight |
| Jan-04-23 | Initiated | Guggenheim | Buy |
| Dec-01-22 | Initiated | Goldman | Buy |
| Sep-21-22 | Initiated | CapitalOne | Overweight |
| May-24-22 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-09-21 | Initiated | JP Morgan | Overweight |
| Aug-12-21 | Initiated | SVB Leerink | Outperform |
| Jun-21-21 | Initiated | Piper Sandler | Overweight |
| Jun-01-20 | Initiated | H.C. Wainwright | Buy |
| May-19-20 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-13-20 | Initiated | ROTH Capital | Buy |
| Nov-25-19 | Initiated | BMO Capital Markets | Outperform |
| Nov-25-19 | Initiated | UBS | Buy |
| Nov-25-19 | Initiated | Wells Fargo | Outperform |
View All
Rapt Therapeutics Inc Stock (RAPT) Latest News
Using data models to predict RAPT Therapeutics Inc. stock movementTrade Entry Summary & Proven Capital Preservation Methods - Newser
Will RAPT Therapeutics Inc. stock go up soonEarnings Summary Report & AI Forecast Swing Trade Picks - Newser
What are RAPT Therapeutics Inc.’s earnings expectationsMarket Risk Analysis & Technical Buy Zone Confirmation - خودرو بانک
Is RAPT Therapeutics Inc. stock influenced by commodity pricesIPO Watch & Growth Focused Entry Reports - خودرو بانک
Rapt Therapeutics (NASDAQ:RAPT) Stock Rating Upgraded by Wall Street Zen - Defense World
Trend analysis for RAPT Therapeutics Inc. this weekMarket Sentiment Summary & Verified Technical Trade Signals - Newser
Candlestick signals on RAPT Therapeutics Inc. stock todayJuly 2025 Intraday Action & Daily Volume Surge Trade Alerts - Newser
Multi factor analysis applied to RAPT Therapeutics Inc.July 2025 Update & Technical Pattern Alert System - Newser
RAPT Therapeutics Inc. stock momentum explainedJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
FOMO Trade: Will RAPT Therapeutics Inc. stock hit new highs in YEAROptions Play & Low Drawdown Investment Strategies - خودرو بانک
What high frequency data says about RAPT Therapeutics Inc.July 2025 Institutional & Verified Short-Term Plans - Newser
Can RAPT Therapeutics Inc. disrupt its industryMarket Movers & Verified Technical Trade Signals - خودرو بانک
How to interpret RSI for RAPT Therapeutics Inc. stockInflation Watch & Real-Time Chart Pattern Alerts - Newser
Rapt Therapeutics shares fall 1.96% after-hours following Cantor Global Healthcare Conference. - AInvest
Will RAPT Therapeutics Inc. stock hit new highs in YEAR2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
Price momentum metrics for RAPT Therapeutics Inc. explainedMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
Can RAPT Therapeutics Inc. withstand a market correction2025 Earnings Surprises & Technical Analysis for Trade Confirmation - خودرو بانک
Backtesting results for RAPT Therapeutics Inc. trading strategiesPortfolio Value Report & Safe Entry Momentum Tips - Newser
Will RAPT Therapeutics Inc. outperform during market ralliesMarket Performance Recap & High Accuracy Trade Alerts - خودرو بانک
How high can RAPT Therapeutics Inc. stock goJuly 2025 Technicals & Entry Point Strategy Guides - Newser
Will RAPT Therapeutics Inc. continue its uptrend2025 Stock Rankings & Real-Time Volume Triggers - Newser
Volume spikes in RAPT Therapeutics Inc. stock – what they meanQuarterly Trade Summary & Free Verified High Yield Trade Plans - Newser
Ranking RAPT Therapeutics Inc. among high performing stocks via toolsTrade Exit Summary & Entry Point Confirmation Alerts - Newser
Automated trading signals detected on RAPT Therapeutics Inc.2025 Top Gainers & High Yield Stock Recommendations - Newser
Is RAPT Therapeutics Inc. building a consolidation baseJuly 2025 Institutional & Expert Approved Trade Ideas - Newser
Institutional Tools Highlight Unusual Flow in RAPT Therapeutics Inc.July 2025 Weekly Recap & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Using R and stats models for RAPT Therapeutics Inc. forecastingShare Buyback & AI Powered Market Entry Ideas - Newser
How to recover losses in RAPT Therapeutics Inc. stockQuarterly Risk Review & Weekly Top Gainers Trade List - Newser
Key resistance and support levels for RAPT Therapeutics Inc.Market Activity Summary & AI Driven Stock Price Forecasts - Newser
Will RAPT Therapeutics Inc. see short term momentumQuarterly Portfolio Review & High Return Trade Guides - Newser
Published on: 2025-09-03 07:07:25 - beatles.ru
How to read the order book for RAPT Therapeutics Inc.Trade Risk Assessment & Long-Term Safe Investment Ideas - Newser
Breakout Watch: Can RAPT Therapeutics Inc. disrupt its industry2025 Trade Ideas & Long-Term Growth Plans - خودرو بانک
Analyzing recovery setups for RAPT Therapeutics Inc. investorsProfit Target & Risk Controlled Swing Alerts - Newser
Measuring RAPT Therapeutics Inc.’s beta against major indicesJuly 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Can RAPT Therapeutics Inc. sustain earnings growthWeekly Trade Analysis & Community Consensus Trade Alerts - خودرو بانک
Is RAPT Therapeutics Inc. a play on infrastructure spending2025 Volume Leaders & Safe Entry Zone Tips - خودرو بانک
Will RAPT Therapeutics Inc. outperform tech stocks2025 Support & Resistance & Long Hold Capital Preservation Tips - خودرو بانک
Can RAPT Therapeutics Inc. maintain its current growth rateQuarterly Risk Review & High Conviction Investment Ideas - خودرو بانک
Rapt Therapeutics Inc Stock (RAPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):